
### [NCIT:C7706](http://purl.obolibrary.org/obo/NCIT_C7706)
**Label:** Childhood Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C7209](http://purl.obolibrary.org/obo/NCIT_C7209) (Childhood B Lymphoblastic Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C94794](http://purl.obolibrary.org/obo/NCIT_C94794) (Stage IV Childhood Non-Hodgkin Lymphoma), [NCIT:C94793](http://purl.obolibrary.org/obo/NCIT_C94793) (Stage III Childhood Non-Hodgkin Lymphoma), [NCIT:C94792](http://purl.obolibrary.org/obo/NCIT_C94792) (Stage II Childhood Non-Hodgkin Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C94791](http://purl.obolibrary.org/obo/NCIT_C94791) (Stage I Childhood Non-Hodgkin Lymphoma), [NCIT:C9189](http://purl.obolibrary.org/obo/NCIT_C9189) (Recurrent Childhood Burkitt Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9124](http://purl.obolibrary.org/obo/NCIT_C9124) (Childhood Lymphoblastic Lymphoma), [NCIT:C9187](http://purl.obolibrary.org/obo/NCIT_C9187) (Stage III Childhood Burkitt Lymphoma), [NCIT:C115030](http://purl.obolibrary.org/obo/NCIT_C115030) (Stage II Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9188](http://purl.obolibrary.org/obo/NCIT_C9188) (Stage IV Childhood Burkitt Lymphoma), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C9095](http://purl.obolibrary.org/obo/NCIT_C9095) (Childhood Burkitt Lymphoma), [NCIT:C123394](http://purl.obolibrary.org/obo/NCIT_C123394) (Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C68692](http://purl.obolibrary.org/obo/NCIT_C68692) (Childhood Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C7616](http://purl.obolibrary.org/obo/NCIT_C7616) (Childhood Diffuse Large B-Cell Lymphoma), [NCIT:C5636](http://purl.obolibrary.org/obo/NCIT_C5636) (Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5637](http://purl.obolibrary.org/obo/NCIT_C5637) (Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115369](http://purl.obolibrary.org/obo/NCIT_C115369) (Recurrent Childhood Non-Hodgkin Lymphoma), [NCIT:C115204](http://purl.obolibrary.org/obo/NCIT_C115204) (Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C80299](http://purl.obolibrary.org/obo/NCIT_C80299) (Pediatric Nodal Marginal Zone Lymphoma), [NCIT:C115367](http://purl.obolibrary.org/obo/NCIT_C115367) (Recurrent Childhood Grade III Lymphomatoid Granulomatosis), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C9059](http://purl.obolibrary.org/obo/NCIT_C9059) (Stage IV Childhood Lymphoblastic Lymphoma), [NCIT:C9057](http://purl.obolibrary.org/obo/NCIT_C9057) (Stage II Childhood Lymphoblastic Lymphoma), [NCIT:C9079](http://purl.obolibrary.org/obo/NCIT_C9079) (Childhood Immunoblastic Lymphoma), [NCIT:C9058](http://purl.obolibrary.org/obo/NCIT_C9058) (Stage III Childhood Lymphoblastic Lymphoma), [NCIT:C7210](http://purl.obolibrary.org/obo/NCIT_C7210) (Childhood T Lymphoblastic Lymphoma), [NCIT:C9056](http://purl.obolibrary.org/obo/NCIT_C9056) (Stage I Childhood Lymphoblastic Lymphoma), [NCIT:C9185](http://purl.obolibrary.org/obo/NCIT_C9185) (Stage I Childhood Burkitt Lymphoma), [NCIT:C9186](http://purl.obolibrary.org/obo/NCIT_C9186) (Stage II Childhood Burkitt Lymphoma), [NCIT:C9060](http://purl.obolibrary.org/obo/NCIT_C9060) (Recurrent Childhood Lymphoblastic Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39741](http://purl.obolibrary.org/obo/NCIT_C39741) (Retroperitoneal Inflammatory Myofibroblastic Tumor))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39739](http://purl.obolibrary.org/obo/NCIT_C39739) (Negative Peripheral Blood))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39725](http://purl.obolibrary.org/obo/NCIT_C39725) (Immunodeficiency))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39721](http://purl.obolibrary.org/obo/NCIT_C39721) (Abundance of Small Lymphocytes))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39720](http://purl.obolibrary.org/obo/NCIT_C39720) (Classical Reed-Sternberg Cell))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3972](http://purl.obolibrary.org/obo/NCIT_C3972) (Prostate Fibroma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39719](http://purl.obolibrary.org/obo/NCIT_C39719) (PDGFRalpha Protein Overexpression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39718](http://purl.obolibrary.org/obo/NCIT_C39718) (PDGFRA Gene Mutation))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39717](http://purl.obolibrary.org/obo/NCIT_C39717) (MDM2 Gene Mutation))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression))) 39.90%


